BNS808

Overview

BNS808 is an orally active and selective cannabinoid-1 receptor ( CB 1 R ) antagonist ( IC 50 = 0.8 nM) with notable CB 2 R selectivity and minimal brain penetration. BNS808 is studied in research on obesity and its associated metabolic complications, such as metabolic dysfunctional-associated steatotic liver disease (MASLD). BNS808 has reduced free drug availability for CNS entry, enhancing safety and minimizing drug-drug interactions through high plasma binding.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Cannabinoid Receptor | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-172808
• CAS No.: 2836313-12-1
• Molecular Formula: C25H20Cl3N3O3S
• Molecular Weight: 548.87
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source